Inside the Technology Behind Extended-Release ADHD Medications

"Inside the Technology Behind Extended-Release ADHD Medications" pulls back the curtain on the microparticle and polymer engineering that gives modern extended-release stimulants their predictable, all-day effect.

The panel takes a deep dive into how extended-release ADHD formulations have evolved. No new stimulant chemicals have emerged in years; providers still rely on dexmethylphenidate, racemic methylphenidate, and mixed amphetamine salts. Instead, innovation has focused on delivery systems engineered for quicker onset and far less batch-to-batch variability, so patients no longer experience unpredictable side effects one day and reduced efficacy the next. One panelist explains two newer mixed-amphetamine medications built on microparticle technology. The first mimics traditional mixed amphetamine salts, using hundreds of thousands of microparticles, half uncoated for immediate release and half coated to release later at a specific pH, producing quick onset with a predictable, roughly eight-hour duration. The second uses up to a million negatively charged microparticles surrounded by diffusion-barrier polymers of varying thickness, so amphetamine is released gradually as ions work through each layer, producing the longest duration of action and the least need for an immediate-release booster.

That same microparticle platform has been adapted into a liquid and chewable methylphenidate product, and into a 24-hour extended-release liquid clonidine, solving a longstanding problem, since earlier extended-release alpha-adrenergics existed only as tablets that could not be crushed, a real barrier for children and patients who cannot swallow pills. The panel also describes a methylphenidate product engineered to begin releasing medication around hour eight, once it reaches the ascending colon, so a nighttime dose becomes active around waking, though it offers little flexibility in dosing time. A newer dexmethylphenidate formulation adds an immediate-release component onto a prodrug base specifically to extend coverage and reduce the need for an afternoon immediate-release booster.

This episode, "New ADHD Formulations, Patches, and Patient Trust," catalogs the newer patches, liquids, and non-stimulant options expanding the adult ADHD toolkit.